Literature DB >> 29421992

Metabolic cooperation between cancer and non-cancerous stromal cells is pivotal in cancer progression.

Filipa Lopes-Coelho1,2, Sofia Gouveia-Fernandes1,2, Jacinta Serpa1,2.   

Abstract

The way cancer cells adapt to microenvironment is crucial for the success of carcinogenesis, and metabolic fitness is essential for a cancer cell to survive and proliferate in a certain organ/tissue. The metabolic remodeling in a tumor niche is endured not only by cancer cells but also by non-cancerous cells that share the same microenvironment. For this reason, tumor cells and stromal cells constitute a complex network of signal and organic compound transfer that supports cellular viability and proliferation. The intensive dual-address cooperation of all components of a tumor sustains disease progression and metastasis. Herein, we will detail the role of cancer-associated fibroblasts, cancer-associated adipocytes, and inflammatory cells, mainly monocytes/macrophages (tumor-associated macrophages), in the remodeling and metabolic adaptation of tumors.

Entities:  

Keywords:  Cancer metabolism; cancer-associated adipocytes; cancer-associated fibroblasts; microenvironment; tumor-associated macrophages

Mesh:

Year:  2018        PMID: 29421992     DOI: 10.1177/1010428318756203

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  9 in total

Review 1.  The double edge sword of fibrosis in cancer.

Authors:  Chelsea Chandler; Tianshi Liu; Ronald Buckanovich; Lan G Coffman
Journal:  Transl Res       Date:  2019-02-21       Impact factor: 7.012

Review 2.  Molecular insights into the interplay between adiposity, breast cancer and bone metastasis.

Authors:  Sneha Soni; Meaghan Torvund; Chandi C Mandal
Journal:  Clin Exp Metastasis       Date:  2021-02-16       Impact factor: 5.150

3.  Monocytes as Endothelial Progenitor Cells (EPCs), Another Brick in the Wall to Disentangle Tumor Angiogenesis.

Authors:  Filipa Lopes-Coelho; Fernanda Silva; Sofia Gouveia-Fernandes; Carmo Martins; Nuno Lopes; Germana Domingues; Catarina Brito; António M Almeida; Sofia A Pereira; Jacinta Serpa
Journal:  Cells       Date:  2020-01-01       Impact factor: 6.600

Review 4.  Revisiting the Crabtree/Warburg effect in a dynamic perspective: a fitness advantage against sugar-induced cell death.

Authors:  Elisabetta de Alteriis; Fabrizio Cartenì; Palma Parascandola; Jacinta Serpa; Stefano Mazzoleni
Journal:  Cell Cycle       Date:  2018       Impact factor: 4.534

Review 5.  The Effects of Adipocytes on the Regulation of Breast Cancer in the Tumor Microenvironment: An Update.

Authors:  Dinh-Toi Chu; Thuy Nguyen Thi Phuong; Nguyen Le Bao Tien; Dang-Khoa Tran; Tran-Thuy Nguyen; Vo Van Thanh; Thuy Luu Quang; Le Bui Minh; Van Huy Pham; Vo Truong Nhu Ngoc; Kushi Kushekhar; Thien Chu-Dinh
Journal:  Cells       Date:  2019-08-08       Impact factor: 6.600

6.  Unraveling FATP1, regulated by ER-β, as a targeted breast cancer innovative therapy.

Authors:  Cindy Mendes; Filipa Lopes-Coelho; Cristiano Ramos; Filipa Martins; Inês Santos; Armanda Rodrigues; Fernanda Silva; Saudade André; Jacinta Serpa
Journal:  Sci Rep       Date:  2019-10-01       Impact factor: 4.379

7.  Melanoma stimulates the proteolytic activity of HaCaT keratinocytes.

Authors:  Justyna Mazurkiewicz; Aleksandra Simiczyjew; Ewelina Dratkiewicz; Magdalena Kot; Katarzyna Pietraszek-Gremplewicz; Dominika Wilk; Marcin Ziętek; Rafał Matkowski; Dorota Nowak
Journal:  Cell Commun Signal       Date:  2022-09-19       Impact factor: 7.525

Review 8.  KRAS, A Prime Mediator in Pancreatic Lipid Synthesis through Extra Mitochondrial Glutamine and Citrate Metabolism.

Authors:  Isaac James Muyinda; Jae-Gwang Park; Eun-Jung Jang; Byong-Chul Yoo
Journal:  Int J Mol Sci       Date:  2021-05-11       Impact factor: 5.923

Review 9.  The Metabolic Features of Tumor-Associated Macrophages: Opportunities for Immunotherapy?

Authors:  Sonja S Mojsilovic; Slavko Mojsilovic; Victor H Villar; Juan F Santibanez
Journal:  Anal Cell Pathol (Amst)       Date:  2021-08-14       Impact factor: 2.916

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.